Abstract
Aptamers are DNA or RNA oligonucleotide sequences that selectively bind to their target with high affinity and specificity. They are obtained using an iterative selection protocol called SELEX. Several small molecules and proteins have been used as targets. Recently, a variant of this methodology, known as cell-SELEX, has been developed for a new generation of aptamers, which are capable of recognizing whole living cells. We have used this methodology for the selection of aptamers, which show high affinity and specificity for several cancer cells. In this chapter, we describe (1) the process followed for the generation of aptamers capable of recognizing acute leukemia cells (CCRF–CEM cells) and (2) the method of enhancing the selectivity and sensitivity of these aptamers by conjugation with a dual-nanoparticle system, which combines magnetic nanoparticles (MNP) and fluorescent silica nanoparticles (FNP). Specifically, the selected aptamers, which showed dissociation constants in the nanomolar range, have been coupled to MNPs in order to selectively collect and enrich cells from complex matrices, including blood samples. The additional coupling of the aptamer to FNPs offers an excellent and highly sensitive method for detecting cancer cells. In order to prove the potential of this rapid and low-cost method for diagnostic purposes, confocal microscopy was used to confirm the specific collection and detection of target cells in concentrations as low as 250 cells. The final fluorescence of the cells labeled with the nanoparticles was quantified using a fluorescence microplate reader.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Tchinda, J., Volpert, S., McNeil, N., Neumann, T., Kennerknecht, I., et al. (2003) Multicolor karyotyping in acute myeloid leukemia. Leukemia Lymphoma 44, 1843–1853.
Kearney, L., Tosi, S., and Jaju, R. J. (2002) Detection of chromosome abnormalities in leukemia using fluorescence in situ hybridization. Methods Mol Med 68, 7–27.
Faderl, S., Kantarjian, H. M., Talpaz, M., and Estrov, Z. (1998) Clinical significance of cytogenetic abnormalities in adult acute lymphoblastic leukemia. Blood 91, 3995–4019.
Craig, F. E. and Foon, K. A. (2008) Flow cytometric immunophenotyping for hematologic neoplasms. Blood 111, 3941–3967.
Belov, L., De la Vega, O., Dos Remedios, C. G., Mulliganm, S. P., and Christopherson, R. I. (2001) Immunophenotyping of leukemias using a cluster of differentiation antibody microarray. Cancer Res 61, 4483–4489.
Wang, L., Wang, K., Santra, S., Zhao, X., Hilliard, L. R., et al. (2006) Watching silica nanoparticles glow in the biological world. Anal Chem 78, 646A–654A.
Smith, J. E., Wang, L., and Tan, W. (2006) Bioconjugated silica-coated nanoparticles for bioseparation and bioanalysis. Trends Anal Chem 25, 848–855.
Shangguan, D., Li, Y., Tang, Z., Cao, Z. C., Chen, H. W., et al. (2006) Aptamers evolved from live cells as effective molecular probes for cancer study. Proc Natl Acad Sci 103, 11838–11843.
Herr, J. K., Smith, J. E., Medley, C. D., Shangguan, D., and Tan, W. (2006) Aptamer-conjugated nanoparticles for selective collection and detection of cancer cells. Anal Chem 78, 2918–2924.
Smith, J. E., Medley, C. D., Tang, Z., Shangguan, D., Lofton, C., and Tan, W. (2007) Aptamer-conjugated nanoparticles for the collection and detection of multiple cancer cells. Anal Chem 79, 3075–3082.
Acknowledgments
This work was supported by NIH, NCI, and NIGMS grants and by State of Florida Center for NanoBiosensors. M.-C.E. acknowledges financial support from the Departament d’Universitats, Recerca i Societat de la Informació de la Generalitat de Catalunya, Spain.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Estévez, M.C. et al. (2010). Nanoparticle–Aptamer Conjugates for Cancer Cell Targeting and Detection. In: Grobmyer, S., Moudgil, B. (eds) Cancer Nanotechnology. Methods in Molecular Biology, vol 624. Humana Press. https://doi.org/10.1007/978-1-60761-609-2_16
Download citation
DOI: https://doi.org/10.1007/978-1-60761-609-2_16
Published:
Publisher Name: Humana Press
Print ISBN: 978-1-60761-608-5
Online ISBN: 978-1-60761-609-2
eBook Packages: Springer Protocols